Suramab is the brand name of a new combination of drugs made up of suramin and bevacizumab. Suramab has antiangiogenic properties that can be applied to oncological and ophthalmological diseases.The european patent (EP 2186529 B1) was granted in March 2012. The US patent is still pendingThis can be .....
[更多]
Ideal for retrofit interventions on existing roofs, with the possibility of partial or total replacement of the cover, thanks to our fitting element to the existing tilesAccess to restricted areas from the point of view of landscape and historical centersArchitectural integration and color in pitc.....
[更多]
This can be seen in the patent file
[更多]
This patent can use for daily complication risk Assessment of all diabetic patients and save lifes, suffering from the diabetic complications at all around the world. it is more important method than Hemoglobin A1c. Because all diabetic complications can monitorizing using one marker (procalcitonin).....
[更多]
| |< <- | [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] | -> >| |
